Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

H. Bas Bueno-de-Mesquita

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5113992114. Sources: OpenAlex.

Their work

Papers
51 (first author 1, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
115
Papers, trials and grants by year

2011: 3 papers · 2012: 9 papers · 2013: 10 papers · 2014: 6 papers · 2015: 4 papers · 2016: 6 papers · 2017: 3 papers · 2018: 4 papers · 2019: 3 papers · 2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 50 of 51

  1. Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional… Co-author DOI 10.1002/ijc.35196↗
  2. Healthy lifestyle and the risk of pancreatic cancer in the EPIC study. Co-author DOI 10.1007/s10654-019-00559-6↗
  3. Gallbladder disease, cholecystectomy, and pancreatic cancer risk in the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1097/cej.0000000000000572↗
  4. Dietary folate intake and pancreatic cancer risk: Results from the European prospective investigation into cancer and nutrition. First author DOI 10.1002/ijc.31830↗
  5. CA19-9 and apolipoprotein-A2 isoforms as detection markers for pancreatic cancer: a prospective evaluation. Co-author DOI 10.1002/ijc.31900↗
  6. Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study. Co-author DOI 10.1002/ijc.31928↗
  7. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation. Co-author DOI 10.1002/ijc.31047↗
  8. Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations. Last author DOI 10.1002/ijc.31146↗
  9. Lifetime and baseline alcohol intakes and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition study. Co-author DOI 10.1002/ijc.31367↗
  10. Circulating plasma phospholipid fatty acids and risk of pancreatic cancer in a large European cohort. Co-author DOI 10.1002/ijc.31797↗
  11. Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition… Co-author DOI 10.1002/ijc.30590↗
  12. Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study. Co-author DOI 10.1002/ijc.30790↗
  13. Mediterranean diet and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition cohort. Co-author DOI 10.1038/bjc.2017.14↗
  14. Flavonoid and lignan intake and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort. Co-author DOI 10.1002/ijc.30190↗
  15. Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis. Co-author DOI 10.1097/mpa.0000000000000392↗
  16. Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case-Control Consortium (PanC… Co-author DOI 10.1097/mpa.0000000000000635↗
  17. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. Co-author DOI 10.18632/oncotarget.10935↗
  18. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Co-author DOI 10.18632/oncotarget.11041↗
  19. Sweet-beverage consumption and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Last author DOI 10.3945/ajcn.116.130963↗
  20. Plasma carotenoids, vitamin C, retinol and tocopherols levels and pancreatic cancer risk within the European Prospective Investigation into Cancer and Nutritio… Last author DOI 10.1002/ijc.29175↗
  21. TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. Co-author DOI 10.1002/ijc.29590↗
  22. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Co-author DOI 10.1038/ng.3341↗
  23. Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Co-author DOI 10.1093/annonc/mdv236↗
  24. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/ng.3052↗
  25. Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. Co-author DOI 10.1093/annonc/mdu276↗
  26. Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS d… Co-author DOI 10.1093/carcin/bgu010↗
  27. Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Co-author DOI 10.1136/gutjnl-2012-303477↗
  28. Genes-environment interactions in obesity- and diabetes-associated pancreatic cancer: a GWAS data analysis. Co-author DOI 10.1158/1055-9965.epi-13-0437-t↗
  29. Leukocyte telomere length in relation to pancreatic cancer risk: a prospective study. Co-author DOI 10.1158/1055-9965.epi-14-0247↗
  30. Meat and fish consumption and risk of pancreatic cancer: results from the European Prospective Investigation into Cancer and Nutrition. Last author DOI 10.1002/ijc.27637↗
  31. Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and… Last author DOI 10.1002/ijc.27875↗
  32. Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Co-author DOI 10.1007/s10552-012-0078-8↗
  33. Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Co-author DOI 10.1007/s10552-012-0138-0↗
  34. Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European Prospective Investigation into Nutrition a… Last author DOI 10.1016/j.cgh.2013.05.029↗
  35. Allergies and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Co-author DOI 10.1093/aje/kwt052↗
  36. Dietary intake of acrylamide and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Co-author DOI 10.1093/annonc/mdt255↗
  37. Ulcer, gastric surgery and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mdt336↗
  38. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Co-author DOI 10.1136/gutjnl-2012-303006↗
  39. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. Co-author DOI 10.1371/journal.pone.0072311↗
  40. The association of circulating adiponectin levels with pancreatic cancer risk: a study within the prospective EPIC cohort. Co-author DOI 10.1002/ijc.26244↗
  41. Plasma cotinine levels and pancreatic cancer in the EPIC cohort study. Co-author DOI 10.1002/ijc.26452↗
  42. Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Co-author DOI 10.1038/bjc.2012.172↗
  43. Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Co-author DOI 10.1038/bjc.2012.19↗
  44. Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mdr120↗
  45. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Co-author DOI 10.1093/annonc/mdr541↗
  46. Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mds140↗
  47. Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Co-author DOI 10.1093/carcin/bgs151↗
  48. The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC Coho… Co-author DOI 10.1158/1055-9965.epi-11-1139↗
  49. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into … Co-author DOI 10.1007/s00125-011-2316-0↗
  50. Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mdq613↗

Closest collaborators

The 25 strongest of 115 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eric J. Duell · 36 shared papers, 2011–2020 · strength 1.15
  2. Elio Ríboli · 20 shared papers, 2011–2020 · strength 0.62
  3. Malin Sund · 20 shared papers, 2011–2020 · strength 0.59
  4. Rudolf Kaaks · 18 shared papers, 2011–2020 · strength 0.58
  5. Verena Andrea Katzke · 13 shared papers, 2013–2020 · strength 0.56
  6. Paolo Vineis · 16 shared papers, 2011–2019 · strength 0.47
  7. Carlo La Vecchia · 13 shared papers, 2011–2020 · strength 0.45
  8. Weimin Ye · 16 shared papers, 2011–2018 · strength 0.42
  9. Gloria M. Petersen · 13 shared papers, 2011–2020 · strength 0.40
  10. Vinciane Rebours · 7 shared papers, 2017–2020 · strength 0.37
  11. Paige M. Bracci · 13 shared papers, 2011–2016 · strength 0.37
  12. Esther Molina‐Montes · 14 shared papers, 2011–2017 · strength 0.35
  13. Patrick Maisonneuve · 11 shared papers, 2011–2020 · strength 0.35
  14. Sara H. Olson · 11 shared papers, 2011–2020 · strength 0.35
  15. Steve Gallinger · 12 shared papers, 2011–2016 · strength 0.33
  16. Guri Skeie · 9 shared papers, 2013–2019 · strength 0.32
  17. Cristina Bosetti · 9 shared papers, 2011–2020 · strength 0.30
  18. Harvey A. Risch · 10 shared papers, 2011–2016 · strength 0.29
  19. Eva Negri · 8 shared papers, 2011–2020 · strength 0.26
  20. Herbert Yu · 9 shared papers, 2011–2016 · strength 0.25
  21. Paolo Boffetta · 8 shared papers, 2011–2020 · strength 0.24
  22. Elizabeth T. H. Fontham · 9 shared papers, 2011–2016 · strength 0.22
  23. Pietro Ferrari · 5 shared papers, 2013–2020 · strength 0.22
  24. Paul Brennan · 4 shared papers, 2017–2020 · strength 0.22
  25. María‐Dolores Chirlaque · 5 shared papers, 2012–2019 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.